myelin oligodendrocyte glycoprotein antibody-associated disease
myelin oligodendrocyte glycoprotein antibody-associated disease
Explore linked clinical trials. Standard reference: MONDO:104002419 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD) | autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated disease | Active, not recruiting | Phase 3 | 2026-10-09 | NCT05063162 | |
| A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, central nervous system disorder, chronic progressive multiple sclerosis, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromuscular disease, neuromyelitis optica, optic nerve disorder, optic neuritis, spinal cord disorder, stiff-person syndrome | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-09 | NCT07804004 | |
| A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated disease | Active, not recruiting | Phase 3 | 2026-09-04 | NCT05271409 | |
| Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial | autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated disease | Recruiting | Phase 3 | 2026-08-31 | NCT05545384 | |
| Cohort Study on Neuroimmune Diseases in the Reproductive Age | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Guillain-Barre syndrome, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myasthenia gravis, myelin oligodendrocyte glycoprotein antibody-associated disease, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Recruiting | Not stated | 2026-06-17 | NCT07653984 | |
| Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE) | CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Recruiting | Not stated | 2026-06-15 | NCT04106830 | |
| The Italian Multiple Sclerosis and Related Disorders Register | CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Enrolling by invitation | Not stated | 2026-06-09 | NCT07636876 | |
| Headache Prevalence and Phenotype in Myelin Oligodendrocyte Glycoprotein Antibody -Associated Disease (MOGAD) | Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, headache disorder, hypnic headache, immune system disorder, migraine disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder | Not yet recruiting | Not stated | 2026-03-20 | NCT07479212 | |
| Tongji NADs Cohort | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Guillain-Barre syndrome, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, acquired idiopathic inflammatory myopathy, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, chronic inflammatory demyelinating polyradiculoneuropathy, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myasthenia gravis, myelin oligodendrocyte glycoprotein antibody-associated disease, myositis disease, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Not yet recruiting | Not stated | 2026-01-21 | NCT07333196 | |
| Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease | autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-01-08 | NCT06452537 | |
| Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. | CNS demyelinating autoimmune disease, Disease Attributes, Disease Progression, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Recruiting | Not stated | 2025-12-12 | NCT06280755 | |
| Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging | Alzheimer disease, Brain Concussion, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, Concussion, Mild, Craniocerebral Trauma, Epileptic Syndromes, Head Injuries, Closed, Nutritional and Metabolic Diseases, Parkinson disease, TDP-43 proteinopathy, Wounds, Nonpenetrating, acute transverse myelitis, amyotrophic lateral sclerosis, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, brain injury, central nervous system disorder, cognitive disorder, cranial nerve neuropathy, dementia, demyelinating disease, epilepsy, eye disorder, focal epilepsy, immune system disorder, injury, metabolic disease, motor neuron disorder, movement disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, neuromyelitis optica, optic nerve disorder, optic neuritis, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, synucleinopathy, tauopathy, temporal lobe epilepsy | Recruiting | Not stated | 2025-10-01 | NCT07202494 | |
| Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. | CNS demyelinating autoimmune disease, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Recruiting | Not applicable | 2025-03-07 | NCT06865274 | |
| Azathioprine in MOGAD | CNS demyelinating autoimmune disease, Infections, Neuroinflammatory Diseases, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, central nervous system disorder, central nervous system infectious disorder, cranial nerve neuropathy, demyelinating disease, encephalomyelitis, eye disorder, immune system disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, myelitis, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis, spinal cord disorder | Recruiting | Phase 3 | 2025-02-04 | NCT05349006 | |
| Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Infections, Leukoencephalopathies, Neoplasms by Site, Neuroinflammatory Diseases, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, Rasmussen subacute encephalitis, Skin and Connective Tissue Diseases, acute disseminated encephalomyelitis, acute transverse myelitis, anti-NMDA receptor encephalitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, central nervous system lupus, central nervous system vasculitis, cerebrovascular disorder, connective tissue disorder, cranial nerve neuropathy, demyelinating disease, encephalitis, eye disorder, immune system disorder, meningitis, meningoencephalitis, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, myelitis, neoplasm, nervous system disorder, neurodegenerative disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, spinal cord disorder, systemic lupus erythematosus, vascular disorder, vasculitis, viral infection of central nervous system | Recruiting | Not stated | 2024-12-16 | NCT05017142 | |
| Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System | Abnormalities, Multiple, Blood Protein Disorders, CNS demyelinating autoimmune disease, Chronic Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Site, POEMS syndrome, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acquired idiopathic inflammatory myopathy, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, chronic inflammatory demyelinating polyradiculoneuropathy, cranial nerve neuropathy, demyelinating disease, eye disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, monoclonal gammopathy, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myasthenia gravis, myelin oligodendrocyte glycoprotein antibody-associated disease, myositis disease, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Recruiting | Early phase 1 | 2024-10-30 | NCT04561557 | |
| Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Leukoencephalopathies, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, acute disseminated encephalomyelitis, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Recruiting | Not applicable | 2024-09-20 | NCT06474520 | |
| Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Leukoencephalopathies, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, acute disseminated encephalomyelitis, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis | Recruiting | Not stated | 2024-08-07 | NCT06541626 | |
| MS-ResearchBiomarkerS | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myelin oligodendrocyte glycoprotein antibody-associated disease, nervous system disorder, neuromyelitis optica, optic nerve disorder, optic neuritis, relapsing-remitting multiple sclerosis | Recruiting | Not stated | 2024-02-06 | NCT05204459 |